Steven Springmeyer is a distinguished pulmonary and critical care specialist who serves as Indi’s chief medical officer.Prior to working at Indi, Dr. Springmeyer was medical director and vice president of Spiration, a company that specializes in minimally invasive devices for lung conditions, that was acquired by Olympus Corporation in 2010. Earlier in his career he spent 17 years at Virginia Mason Medical Center in Seattle, most recently as director of bronchoscopy and interventional pulmonology and co-director of thoracic oncology. Prior to that, Dr. Springmeyer spent a decade at the University of Washington, rising to become chief of respiratory disease at the Fred Hutchinson Cancer Research Center. He remains a clinical professor of medicine at the University of Washington.Springmeyer holds a B.S. in biology and an M.D. from the University of Utah in Salt Lake City.